In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Sirna Therapeutics licenses intellectual property in the field of RNAi
Nastech to reacquire intranasal Apomorphine product licenses from Pharmacia
AstraZeneca and Silence Therapeutics To Collaborate On Novel Approaches For siRNA Drug Delivery
Nastech reacquires apomorphine rights
Nastech to manufacture Nascobal(R) nasal spray for QOL Medical
Affymetrix and QIAGEN to collaborate on siRNA research
Cellecta Partners with Ariadne to Provide siRNA Pathway Analysis Services